期刊文献+

A novel mitofusin 2 gene mutation causing Charcot-Marie-Tooth type 2A disease in a Chinese family

A novel mitofusin 2 gene mutation causing Charcot-Marie-Tooth type 2A disease in a Chinese family
原文传递
导出
摘要 Charcot-Marie-Tooth disease (CMT), also known as hereditary motor and sensory neuropathies,comprises a genetically heterogeneous group of inherited peripheral neuropathies. Clinically it is characterized by progressive distal weakness, muscle atrophy, distal sensory loss and loss of deep tendon reflexes. Following electrophysiological criteria, CMT is divided into two main forms: Charcot-Marie-Tooth disease (CMT), also known as hereditary motor and sensory neuropathies,comprises a genetically heterogeneous group of inherited peripheral neuropathies. Clinically it is characterized by progressive distal weakness, muscle atrophy, distal sensory loss and loss of deep tendon reflexes. Following electrophysiological criteria, CMT is divided into two main forms:
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第11期1466-1469,共4页 中华医学杂志(英文版)
关键词 Charcot-Marie-Tooth type 2A mitofusin 2 gene Hong Kong Charcot-Marie-Tooth type 2A mitofusin 2 gene Hong Kong
  • 相关文献

参考文献15

  • 1Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types Ⅰ and Ⅱ. Brain 1980; 103: 259-280.
  • 2Verhoeven K, Claeys KG, Zuchner S, Schroder JM, Weis J, Ceuterick C, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006; 129: 2093-2102.
  • 3England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72: 185-192.
  • 4Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1BI3. Cell 2001; 105: 587-597.
  • 5Zuchner S, Mersiyanova IV, Rochelle J, Dadali EL, et al Muglia M, Bissar-Tadmouri N, Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36: 449-451.
  • 6Cartoni R, Martinou JC. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Exp Neurol 2009; 218: 268-273.
  • 7Del Bo R, Moggio M, Rango M, Bonato S, D'Angelo MG, Ghezzi S, et al. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology 2008; 71: 1959-1966.
  • 8Ajroud-Driss S, Fecto F, Ajroud K, Yang Y, Donkervoort S, Siddique N, et al. A novel de novo MFN2 mutation causing CMT2A with upper motor neuron signs. Neurogenetics 2009; 10: 359-361.
  • 9Chung KW, Kim SB, Park KD, Choi KG, Lee JH, Eun HW, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 2006; 129: 2103-2118.
  • 10Ztichner S, De Jonghe R Jordanova A, Claeys KG, Guergueltcheva V, Cherninkova S, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006; 59: 276-281.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部